Literature DB >> 19459089

Hypnotherapy for functional gastrointestinal disorders: a review.

Vivien Miller1, Peter J Whorwell.   

Abstract

Patients with functional gastrointestinal disorders, such as irritable bowel syndrome, functional dyspepsia, and noncardiac chest pain, can suffer from a range of severe symptoms that often substantially erode quality of life. Unfortunately, these conditions are notoriously difficult to treat, with many patients failing to improve despite being prescribed a wide variety of conventional medications. As a consequence, the potential benefits of hypnotherapy have been explored with evidence that this approach not only relieves symptoms but also appears to restore many of the putative psychological and physiological abnormalities associated with these conditions toward normal. These observations suggest that this form of treatment has considerable potential in aiding the management of functional gastrointestinal disorders and should be integrated into the ongoing medical care that these patients are receiving.

Entities:  

Mesh:

Year:  2009        PMID: 19459089     DOI: 10.1080/00207140902881098

Source DB:  PubMed          Journal:  Int J Clin Exp Hypn        ISSN: 0020-7144


  17 in total

1.  Therapeutic mechanisms of a mindfulness-based treatment for IBS: effects on visceral sensitivity, catastrophizing, and affective processing of pain sensations.

Authors:  Eric L Garland; Susan A Gaylord; Olafur Palsson; Keturah Faurot; J Douglas Mann; William E Whitehead
Journal:  J Behav Med       Date:  2011-12-08

2.  IBS: Hypnotherapy--a wasted resource?

Authors:  Peter J Whorwell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-12-06       Impact factor: 46.802

3.  Hypnotherapy for Esophageal Disorders.

Authors:  Megan E Riehl; Laurie Keefer
Journal:  Am J Clin Hypn       Date:  2015-07

Review 4.  New treatments for IBS.

Authors:  Magnus Halland; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-13       Impact factor: 46.802

5.  Feasibility and acceptability of esophageal-directed hypnotherapy for functional heartburn.

Authors:  M E Riehl; J E Pandolfino; O S Palsson; L Keefer
Journal:  Dis Esophagus       Date:  2015-03-30       Impact factor: 3.429

Review 6.  Stress and visceral pain: from animal models to clinical therapies.

Authors:  Muriel Larauche; Agata Mulak; Yvette Taché
Journal:  Exp Neurol       Date:  2011-05-06       Impact factor: 5.330

7.  Mood color choice helps to predict response to hypnotherapy in patients with irritable bowel syndrome.

Authors:  Helen R Carruthers; Julie Morris; Nicholas Tarrier; Peter J Whorwell
Journal:  BMC Complement Altern Med       Date:  2010-12-07       Impact factor: 3.659

Review 8.  Why dyspepsia can occur without organic disease: pathogenesis and management of functional dyspepsia.

Authors:  Hiroto Miwa
Journal:  J Gastroenterol       Date:  2012-07-06       Impact factor: 7.527

Review 9.  Refractory inflammatory bowel disease-could it be an irritable bowel?

Authors:  Jie Meng; Anurag Agrawal; Peter J Whorwell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-09-11       Impact factor: 46.802

Review 10.  Aspects of the non-pharmacological treatment of irritable bowel syndrome.

Authors:  Elsa Maria Eriksson; Kristina Ingrid Andrén; Göran Karl Kurlberg; Henry Ture Eriksson
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.